Alkaloid AD Skopje has 75 years’ experience manufacturing drugs, botanicals, cosmetics and chemical products. As a joint stock company employing an international team of 1,300 people, the firm operates worldwide through its sister company Alkaloid KONS (responsible for distribution and marketing of other producers’ products) and its subsidiaries in Serbia, Montenegro, Kosovo, Albania, Bosnia and Herzegovina, Croatia, Slovenia, Switzerland, Bulgaria, Romania, Ukraine, the Russian Federation and the US.
In 2010, Alkaloid AD Skopje achieved total consolidated sales of .96.5 million. The firm offers a broad range of pharmaceutical products, from solid to liquid forms. In 2002, it finished building two new factories: one for solid dosage forms with an annual capacity of two billion dose units; and the other for semisynthetic cephalosporins (200 million capsules and 3.5 million bottles of dry powder for oral suspension). Both facilities meet international quality standards ISO 9001 and CGMP. Being GMPcertified by the MHRA, Romania’s National Medicines Agency and Slovenia’s JAZMP allows Alkaloid to position its solid dosage forms, cephalosporins and non-sterile liquids throughout the EU.
The CE Marking of Conformity issued by KEMA Quality also grants Alkaloid the right to place its haemodialysis solutions and X-ray films in the EU. With more than 1,000 marketing authorisations worldwide, in 2010, PC Pharmaceuticals’ products were available on the markets of 21 countries. With profound regulatory, marketing and sales and expertise in south-east Europe, Alkaloid is open for all kinds of cooperation, including:
- licensing of registration dossiers
- co-development
- contract manufacturing in solid dosage forms, cephalosporins, non-sterile liquids and haemodialysis solutions
- marketing or co-marketing
- distribution activities
- mutual launching of new products, gaining mutual access to new markets.
Alkaloid also participates in the niche market of morphinebased products,